Irinotecan in Treating Aging Patients With Solid Tumors
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Aging may affect the way these drugs work.
PURPOSE: Phase I trial to determine the relationship between aging and the effectiveness of
irinotecan in treating patients who have solid tumors.